Skip to menu Skip to content Skip to footer

2015

Journal Article

N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients

Fahim, Magid A, Hayen, Andrew, Horvath, Andrea R, Dimeski, Goce, Coburn, Amanda, Johnson, David W, Hawley, Carmel M, Campbell, Scott B and Craig, Jonathan C (2015). N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients. Clinical Journal of the American Society of Nephrology, 10 (4), 620-629. doi: 10.2215/CJN.09060914

N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients

2015

Journal Article

Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice

Fahim, Magid A., Hayen, Andrew D., Horvath, Andrea R., Dimeski, Goce, Coburn, Amanda, Tan, Ken-Soon, Johnson, David W., Craig, Jonathan C., Campbell, Scott B. and Hawley, Carmel M. (2015). Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clinical Chemistry and Laboratory Medicine, 53 (5), 715-722. doi: 10.1515/cclm-2014-0838

Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice

2015

Journal Article

The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study

Roberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Hawley, Carmel M., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Tonkin, Andrew M., Vergara, Liza A., Perkovic, Vlado and The BLOCADE Study Collaborative Group (2015). The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study. Nephrology, 20 (3), 140-147. doi: 10.1111/nep.12362

The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study

2015

Journal Article

The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis

Stevenson, Sarah, Tang, Wen, Cho, Yeoungjee, Mudge, David W., Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2015). The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 35 (2), 222-228. doi: 10.3747/pdi.2013.00156

The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis

2015

Journal Article

Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Clarke, Margaret and Topley, Nicholas (2015). Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial. Peritoneal Dialysis International, 35 (2), 159-171. doi: 10.3747/pdi.2013.00170

Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial

2015

Journal Article

End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry cases

Mallett, Andrew, Tang, Wen, Hart, Gareth, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Campbell, Scott B., Clayton, Philip A. and Johnson, David W. (2015). End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry cases. American Journal of Nephrology, 42 (3), 177-184. doi: 10.1159/000440815

End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry cases

2015

Conference Publication

Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Cho, Yeoungjee, Hawley, Carmel, Pascoe, Elaine, Clayton, Philip A., Leblanc, Martine, Boudville, Neil, Polkinghorne, Kevan R. and Johnson, David W. (2015). Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study. 52nd Congress of the European Renal Association European Dialysis and Transplant Assocation, London, United Kingdom, 28-31 May 2015. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv180.10

Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study

2015

Conference Publication

FP556 Predictors of transfer to home hemodialysis after definitive peritoneal dialysis completion

Nadeau-Fredette, Annie-Claire, Chan, Christopher T, Hawley, Carmel, Pascoe, Elaine, Leblanc, Martine, Clayton, Philip A, Polkinghorneghorne, Kevan R, Boudville, Neil and Johnson, David W. (2015). FP556 Predictors of transfer to home hemodialysis after definitive peritoneal dialysis completion. 52nd ERA-EDTA Congress, London, United Kingdom, 28th-31st May 2015. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv180.08

FP556 Predictors of transfer to home hemodialysis after definitive peritoneal dialysis completion

2015

Journal Article

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial

Johnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., on behalf of the HERO Study Collaborative Group and Fassett, Rob (2015). A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 (1), 49-57. doi: 10.1053/j.ajkd.2014.06.020

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial

2015

Conference Publication

Scope and consistency of outcomes reported in randomised trials of haemodialysis

Williams, G. J., Tong, A., Manns, B., Hemmelgarn, B., Wheeler, D. C., Tugwell, P., Winkelmayer, W. C., Van Biesen, W., Kerr, P. G., Polkinghorne, K. R., Howard, K., Pollock, C., Hawley, C. M., Johnson, D. W., Mcdonald, S. P., Gallagher, M. P., Urquhart-Secord, R. and Craig, J. C. (2015). Scope and consistency of outcomes reported in randomised trials of haemodialysis. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, ACT Australia, 7-9 September 2015. HOBOKEN: WILEY-BLACKWELL.

Scope and consistency of outcomes reported in randomised trials of haemodialysis

2015

Conference Publication

Association between left ventricular global longitudinal strain, functional capacity and quality of life in patients with chronic kidney disease

Stanton, Tony, Krishnasamy, Rathika, Hawley, Carmel M., Howden, Erin, Beetham, Kassia, Strand, Haakan, Leano, Rodel L., Haluska, Brian A., Coombes, Jeff S. and Isbel, Nicole M. (2015). Association between left ventricular global longitudinal strain, functional capacity and quality of life in patients with chronic kidney disease. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting, Melbourne, VIC, Australia, 13-16 August 2015. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2015.06.502

Association between left ventricular global longitudinal strain, functional capacity and quality of life in patients with chronic kidney disease

2015

Conference Publication

Chronic kidney disease is associated with progressive increase in arterial stiffness and bone-muscle loss over 1 year

Krishnasamy, R., Isbel, N. M., Johnson, D. W., Stanton, T., Fiumara, F., Bolwell, J., Vaneps, C., Mudge, D. W., Campbell, S., Tan, S. J., Toussaint, N. D. and Hawley, C. M. (2015). Chronic kidney disease is associated with progressive increase in arterial stiffness and bone-muscle loss over 1 year. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, Australia, 7-9 September 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12543

Chronic kidney disease is associated with progressive increase in arterial stiffness and bone-muscle loss over 1 year

2015

Conference Publication

Predictors of Transfer to Home Hemodialysis After Definitive Peritoneal Dialysis Completion

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Hawley, Carmel, Pascoe, Elaine, Leblanc, Martine, Clayton, Philip A., Polkinghorneghorne, Kevan R., Boudville, Neil and Johnson, David W. (2015). Predictors of Transfer to Home Hemodialysis After Definitive Peritoneal Dialysis Completion. 52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London England, May 28-31, 2015. OXFORD: Wiley-Blackwell. doi: 10.1093/ndt/gfv180.8

Predictors of Transfer to Home Hemodialysis After Definitive Peritoneal Dialysis Completion

2015

Journal Article

Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret and Topley, Nicholas (2015). Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients. Peritoneal Dialysis International, 35 (1), 35-42. doi: 10.3747/pdi.2013.00272

Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients

2015

Conference Publication

Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients

Badve, S. V., Burke, M., Clayton, P., Campbell, S. B., Hawley, C. M., Lim, W. H., Mcdonald, S. P., Pascoe, E., Wong, G. and Johnson, D. W. (2015). Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, ACT Australia, 7-9 September 2015. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12543

Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients

2015

Journal Article

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Cho, Yeoungjee, Hawley, Carmel M., Pascoe, Elaine M., Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil, Leblanc, Martine and Johnson, David W. (2015). Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study. Nephrology Dialysis Transplantation, 30 (11), 1897-1904. doi: 10.1093/ndt/gfv132

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study

2014

Journal Article

The association between body mass index and mortality in incident dialysis patients

Badve S.V., Paul S.K., Klein K., Clayton P.A., Hawley C.M., Brown F.G., Boudville N., Polkinghorne K.R., McDonald S.P. and Johnson D.W. (2014). The association between body mass index and mortality in incident dialysis patients. PLoS ONE, 9 (12) e114897, 1-13. doi: 10.1371/journal.pone.0114897

The association between body mass index and mortality in incident dialysis patients

2014

Journal Article

End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases

Mallett, Andrew, Tang, Wen, Clayton, Philip A., Stevenson, Sarah, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Campbell, Scott B. and Johnson, David W. (2014). End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases. Nephrology Dialysis Transplantation, 29 (12), 2277-2286. doi: 10.1093/ndt/gfu254

End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases

2014

Journal Article

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Clayton, Philip and Johnson, David W. (2014). Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis. Nephrology, Dialysis, Transplantation, 29 (10), 1940-1947. doi: 10.1093/ndt/gfu050

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

2014

Journal Article

Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study

Rossi, M., Campbell, K., Johnson, D., Stanton, T., Pascoe, E., Hawley, C., Dimeski, G., McWhinney, B., Ungerer, J. and Isbel, N. (2014). Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study. Nutrition, Metabolism and Cardiovascular Diseases, 24 (9), 1035-1042. doi: 10.1016/j.numecd.2014.04.006

Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study